HOME > TOP STORIES
TOP STORIES
-
BUSINESS Kobayashi Kako Chief to Resign over Drug Mix-Up, Lousy Manufacturing and Cover-Ups
February 10, 2021
-
REGULATORY Kobayashi Kako Slapped with Record 116-Day Business Suspension
February 9, 2021
-
REGULATORY Pfizer’s COVID-19 Shot Up for PAFSC Review Feb. 12, Kono Expects Govt to Secure Enough Doses for 1st-in-Line HCPs
February 9, 2021
-
BUSINESS 7 Japan Drug Majors See 2.7% Revenue Fall in FY2020, COVID-19 Forces Cuts on Guidance: Jiho Tally
February 8, 2021
-
BUSINESS Health Minister Hails Domestic Production Plan for AstraZeneca Vaccine
February 8, 2021
-
BUSINESS AstraZeneca Files COVID-19 Vaccine in Japan
February 5, 2021
-
BUSINESS MSD to Launch Silgard 9 on Feb. 24, but Mass Supply in Japan Unlikely Until 2023
February 5, 2021
-
BUSINESS Gilead Mulling Japan Entry into PIII Study for Inhaled Version of Veklury
February 5, 2021
-
BUSINESS Drug Makers Moving to Discontinue Ranitidine/Nizatidine Products over Carcinogen Issue
February 4, 2021
-
REGULATORY Celgene’s Liso-Cel Up for PAFSC Review on Feb. 17, 3rd CAR-T Therapy in Japan
February 4, 2021
-
BUSINESS Eisai Neurology Chief Says Partners Continue to Stand Behind Aducanumab
February 4, 2021
-
ORGANIZATION PhRMA Prods Japan to Harness Power of RWD in Drug Development, Medical Care Evaluation
February 3, 2021
-
REGULATORY Japan Moves Up Vaccine Rollout Target to Mid-February, PAFSC Review on Feb. 12?
February 3, 2021
-
INTERVIEW Alzheimer’s Treatment at Crossroads? Top Expert on AD Research, Aducanumab and Its Implications - 1
February 2, 2021
-
BUSINESS Teijin to Acquire Fujifilm's J-TEC for Up to 21.6 Billion Yen
February 1, 2021
-
BUSINESS FDA Delays Decision for Biogen’s Aducanumab to June 7
February 1, 2021
-
REGULATORY MHLW Wants to Encourage Non-Monitoring Facilities to Report Inappropriate Drug Promotion
January 29, 2021
-
BUSINESS Kobayashi Kako Issues Yet Another Recall, Now for 12 APIs/21 Products
January 28, 2021
-
REGULATORY Kobayashi Kako Might Face 116-Day Biz Suspension over Drug Mix-Up
January 27, 2021
-
REGULATORY Kobayashi Kako Notified of Record Biz Suspension of 110-Plus Days over Drug Mix-Up
January 26, 2021
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
